Evidence map›Paper›PMID 26045048›Full record

ArticleCell death and differentiation2016

Protein kinase D1/2 is involved in the maturation of multivesicular bodies and secretion of exosomes in T and B lymphocytes.

C Mazzeo, V Calvo, R Alonso, I Mérida, M Izquierdo

Open access · bronzeAbstract read
In one paragraph

Article in Cell death and differentiation, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 91 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. The theragnostic advances of exosomes in managing leukaemia.Journal of cellular and molecular medicine · 2024
    Review
  9. Article
  10. Review
  11. Therapeutic Applications of Stem Cell-Derived Exosomes.International journal of molecular sciences · 2024
    Review
  12. Article
  13. Emerging role of exosomes in hematological malignancies.Clinical and experimental medicine · 2023
    Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

C MazzeoDepartamento de Bioquímica, Instituto de Investigaciones Biomédicas Alberto Sols CSIC-UAM Madrid, Madrid, Spain.
V CalvoDepartamento de Bioquímica, Instituto de Investigaciones Biomédicas Alberto Sols CSIC-UAM Madrid, Madrid, Spain.
R AlonsoDepartamento de Bioquímica, Instituto de Investigaciones Biomédicas Alberto Sols CSIC-UAM Madrid, Madrid, Spain.
I MéridaDepartment of Immunology and Oncology, Centro Nacional de Biotecnología CSIC, Madrid, Spain.
M IzquierdoDepartamento de Bioquímica, Instituto de Investigaciones Biomédicas Alberto Sols CSIC-UAM Madrid, Madrid, Spain.ORCID http://orcid.org/0000-0002-7701-1002
Instituto de Investigaciones Biomédicas Sols-Morreale · ESCentro Nacional de Biotecnología · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Multivesicular bodies (MVBs) are endocytic compartments that enclose intraluminal vesicles (ILVs) formed by inward budding from the limiting membrane of endosomes. In T lymphocytes, these ILV contain Fas ligand (FasL) and are secreted as 'lethal exosomes' following activation-induced fusion of the MVB with the plasma membrane. Diacylglycerol (DAG) and diacylglycerol kinase α (DGKα) regulate MVB maturation and polarized traffic, as well as subsequent secretion of pro-apoptotic exosomes, but the molecular basis underlying these phenomena remains unclear. Here we identify protein kinase D (PKD) family members as DAG effectors involved in MVB genesis and secretion. We show that the inducible secretion of exosomes is enhanced when a constitutively active PKD1 mutant is expressed in T lymphocytes, whereas exosome secretion is impaired in PKD2-deficient mouse T lymphoblasts and in PKD1/3-null B cells. Analysis of PKD2-deficient T lymphoblasts showed the presence of large, immature MVB-like vesicles and demonstrated defects in cytotoxic activity and in activation-induced cell death. Using pharmacological and genetic tools, we show that DGKα regulates PKD1/2 subcellular localization and activation. Our studies demonstrate that PKD1/2 is a key regulator of MVB maturation and exosome secretion, and constitutes a mediator of the DGKα effect on MVB secretory traffic.

Indexed as

AnimalsB-LymphocytesCell DeathDiacylglycerol KinaseExosomesFas Ligand ProteinMiceMultivesicular BodiesProtein Kinase CProtein Kinase D2Protein KinasesT-LymphocytesDiacylglycerol KinaseFas Ligand ProteinFasl protein, mouseProtein Kinase Cprotein kinase DProtein Kinase D2Protein Kinases

Identifiers

PMID26045048
PMCPMC4815981
OpenAlexW1600369124

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.